1. Home
  2. FLUX vs LEXX Comparison

FLUX vs LEXX Comparison

Compare FLUX & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flux Power Holdings Inc.

FLUX

Flux Power Holdings Inc.

HOLD

Current Price

$1.27

Market Cap

34.4M

Sector

Miscellaneous

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.63

Market Cap

14.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLUX
LEXX
Founded
N/A
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.4M
14.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FLUX
LEXX
Price
$1.27
$0.63
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$6.00
$1.50
AVG Volume (30 Days)
293.2K
1.5M
Earning Date
11-13-2025
01-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$63,484,000.00
$705,923.00
Revenue This Year
$0.18
$13.35
Revenue Next Year
$29.72
$78.83
P/E Ratio
N/A
N/A
Revenue Growth
2.13
52.05
52 Week Low
$1.15
$0.46
52 Week High
$7.55
$2.43

Technical Indicators

Market Signals
Indicator
FLUX
LEXX
Relative Strength Index (RSI) 32.42 37.99
Support Level $1.33 $0.46
Resistance Level $1.48 $0.58
Average True Range (ATR) 0.11 0.12
MACD 0.05 -0.03
Stochastic Oscillator 5.00 16.88

Price Performance

Historical Comparison
FLUX
LEXX

About FLUX Flux Power Holdings Inc.

Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: